RICHARD CLAYTOR: Open Payments
NPI 1376633610 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 37 payments from 8 companies in 2025. Trend: 2023 $378 · 2024 $2,809 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $391 |
| Neuronetics, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Corium, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: Qelbree, NEUROSTAR TMS THERAPY SYSTEM, Jornay PM, Azstarys, ABILIFY MAINTENA, CAPLYTA, COBENFY, VRAYLAR.
Industry payments across VA — which companies pay providers there.
